Massachusetts General Hospital
Fri Dec 7, 2018 on Facebook
Joint infection is a serious and disabling potential complication of total joint replacement surgery and occurs in 1 in 100 patients. Given the significant population at risk, the need to prevent or reduce joint infections is urgent. Researchers in the Harris Orthopaedics Laboratory have developed a promising new drug-eluting joint implant that may substantially reduce the infection rate. #MassGeneralAdvances